CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Recruiting · NCT07053462 · Registry updated 2025-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, chronic kidney disease, chronic renal failure syndrome, epithelial neoplasm, kidney cancer, kidney disorder, kidney failure, kidney neoplasm, neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2025-07-08 | NCT07053462 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University Health Science Center (PKUHSC) | Beijing | China | 2 |